AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod
المصدر: NASDAQ Stocks / 02 أبريل 2024 09:15:53 America/Chicago
AstraZeneca AZN announced that the FDA had approved Voydeya (danicopan) for treating paroxysmal nocturnal hemoglobinuria (PNH), a rare and chronic blood disorder.
https://www.nasdaq.com/articles/astrazenecas-azn-rare-blood-disorder-drug-gets-fda-nod